About PSM
Are Canadian patients struggling with drug shortages already?
PSM’s Shabbir Imber Safdar speaks to Canadian patient advocate Durhane Wong-Rieger about the drug shortage situation in Canada.
[...]What medicines do U.S. states want to import from Canada’s drug supply?
What drugs have states said they plan to export from Canada’s drug supply? We combed all their applications to the FDA and compiled that list into one document.
[...]The Partnership for Safe Medicines supports S. 2943, the SHOP SAFE Act
On January 17, 2024 PSM wrote the Senate Subcommittee on Intellectual Property to endorse S.2934, which would expand the Trademark Act of 1946 to extend liability for selling harmful counterfeits to online platforms. Read the letter here.
[...]Partnership for Safe Medicines Condemns the Weakening of the U.S. Drug Supply through Canadian Drug Importation + Full coverage of decision
PSM’s statement on the FDA decision and full coverage including media stories, official documents, and statements from stakeholders.
[...]PSM Executive Director to Speak at USPTO Roundtable on Counterfeits
Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, will participate in the upcoming United States Patent and Trademark Office Roundtable: Future strategies in anti-counterfeiting and anti-piracy.
[...]PSM and ADAP Advocacy call for more awareness about counterfeit medicines
Data recently shared in the Morbidity and Mortality Weekly Report highlights a growing problem: Counterfeit pill availability is rising in the drug supply chain, but also the illicit drug market.
[...]Teach Your Community With These Conference Slides
Running slides between conference sessions and during breaks is a great way to fit in a little extra information. Use these slides to teach your community about counterfeit medicines in the U.S.
[...]PSM submits comment on USPTO anti-counterfeiting initiative
On August 3, the Partnership for Safe Medicines submitted comment on the U.S. Patent and Trademark Office’s Future Strategies in Anticounterfeiting and Antipiracy.
[...]Texas State Senate Passes Dangerous Foreign Drug Importation Program
With the passage of HB 25 in the Texas State Senate and Governor Abbott’s impending signature, Texas is poised to become the seventh state in the U.S. to attempt to create a program to import medicine from Canada. This policy has failed in six other states, cost taxpayers millions of dollars, and drawn opposition from the Canadian government.
[...]Protect Your Patients and Your Practice
PSM and the American Medical Women’s Association worked together on this resource, which tells physicians the basics about counterfeit medicine.
[...]